BioSpace News Archive

Policy

Biopharma Update on the Novel Coronavirus: June 29

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.

June 29, 2020
·
2 min read
·
BioSpace Editorial Staff
Deals

Report: Biotech IPOs Gave Healthcare Industry a Boost in Q2 2020

Specifically, the report indicated that biotechnology companies drove the healthcare industry to make up almost two-thirds of IPO activity in the second quarter of 2020.

June 29, 2020
·
2 min read
·
Krystle Vermes
Drug Development

Two Patient Deaths Halt Audentes’ Gene Therapy Trial

San Francisco-based Audentes Therapeutics reported two deaths in its gene therapy clinical trial. The therapy, AT132, is for X-linked myotubular myopathy.

June 29, 2020
·
3 min read
·
Mark Terry
Business

Gilead Outlines Pricing Plans for Coronavirus Treatment Remdesivir

Gilead Sciences set the price of the only approved treatment for COVID-19, remdesivir, at $390 per vial, which for most patients receiving a 5-day treatment using six vials, would come to $2,340 per patient.

June 29, 2020
·
3 min read
·
Mark Terry
Policy

Heron Receives Rejection from FDA for Non-Opioid Pain Drug HTX-011

The U.S. Food and Drug Administration (FDA) issued Heron Therapeutics a Complete Response Letter (CRL) for its New Drug Application (NDA) for HTX-011 for the management of postoperative pain.

June 29, 2020
·
2 min read
·
Mark Terry
Business

DBV Tech Cuts Jobs While Waiting on FDA Review of Peanut Allergy Patch

DBV Technologies, located just outside Paris, announced it is cutting jobs while it awaits news from the U.S. Food and Drug Administration (FDA) about its application for Viaskin Peanut.

June 29, 2020
·
3 min read
·
Mark Terry
Drug Development

Salt Water Gargle Vs. COVID-19: Researchers Launch Study to Lessen Symptoms and Duration of Illness

Salt water gargle is a time-tested way to alleviate sore-throat pain. It can help clear stuffy sinuses. But, is it effective against the symptoms of COVID-19?

June 29, 2020
·
4 min read
·
Gail Dutton
BioNTech Receives More Funding on Its Path Toward a COVID-19 Vaccine

Clinical-stage biotechnology company BioNTech announced a private investment of $250 million today, led by Temasek and other investors.

June 29, 2020
·
3 min read
·
Krystle Vermes
Deals

Flexwise Health Completes Merger with Prescience Health

Flexwise Health, an on-demand clinical staffing platform for hospitals, and Prescience Health, a staffing optimization software company that uses data science to predict patient demand and align nurses, today announced that they have completed their merger to form one company.

June 29, 2020
·
3 min read
Pharm Country

Christopher & Dana Reeve Foundation Announces Direct Effect Quality of Life Grants for 2020

The Christopher & Dana Reeve Foundation National Paralysis Resource Center announced that it is funding fifty-two Direct Effect Quality of Life Grants, totaling $918,046.

June 29, 2020
·
4 min read